Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10001744 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL9543017 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL487563 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL6233713 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL10001742 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL1692429 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL8168248 | 1.00 | TSHR (0.67) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL16477739 | 0.90 | EPHX1 (0.61) | TSHREPHX1POLBCYP2D6ALDH1A1 | |
| SCHEMBL15446214 | 0.87 | TSHR (0.53) | TSHREPHX1POLBALDH1A1MAPT | |
| SCHEMBL7902731 | 0.85 | TSHR (0.54) | TSHREPHX1ALDH1A1MAPTITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8106231-B2 | Process for the preparation of (2R,3S)-3-phenylisoserine methyl ester acetate salt | INDENA S.P.A. (IT) | 2012-01-31 | — | — | US | disclosed |
| US-20100168460-A1 | PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT | INDENA S.P.A. (IT) | 2010-07-01 | — | — | US | disclosed |
| EP-1961735-B1 | Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt | INDENA SPA (IT) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008101608-A1 | PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT | INDENA S.P.A. (IT) | 2008-08-28 | — | — | WO | disclosed |
| EP-1961735-A1 | Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt | Indena S.P.A. (IT) | 2008-08-27 | — | — | EP | disclosed |
| EP-1412319-A1 | CHIRAL RESOLUTION METHOD FOR PRODUCING COMPOUNDS USEFUL IN THE SYNTHESIS OF TAXANES | NAPRO BIOTHERAPEUTICS, INC. (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6653501-B2 | Using chromatographic process for separating a target chiral compound from its enantiomer in a racemic mixtures; purification | NAPRO BIOTHERAPEUTICS, INC. | 2003-11-25 | — | — | US | disclosed |
| US-20030045743-A1 | Chiral resolution method for producing compounds useful in the synthesis of taxanes | MAYNE PHARMA (USA), INC. | 2003-03-06 | — | — | US | disclosed |
| WO-2003002509-A1 | CHIRAL RESOLUTION METHOD FOR PRODUCING COMPOUNDS USEFUL IN THE SYNTHESIS OF TAXANES | NAPRO BIOTHERAPEUTICS, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| US-5663393-A | CYCLIZATION; DECYCLIZATION; HYDROLYSIS; HYDROGENATION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-09-02 | — | — | US | disclosed |
| US-5637739-A | ORGANOMETALLIC CATALYSTS FOR ENANTIOSELECTIVELY EPOXIDIZING PROCHIRAL OLEFINS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| WO-1993010076-A1 | SYNTHESIS AND OPTICAL RESOLUTION OF THE TAXOL SIDE CHAIN AND RELATED COMPOUNDS | THE UNIVERSITY OF MISSISSIPPI (US) | 1993-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045743-A1 | Chiral resolution method for producing compounds useful in the synthesis of taxanes | CCNK, OPRK1, SYMPK | TSHR 3694/4885EPHX1 1034/4885POLB 3966/4885 |
| US-20100168460-A1 | PROCESS FOR THE PREPARATION OF (2R,3S)-3-PHENYLISOSERINE METHYL ESTER ACETATE SALT | SPTSSB, SRR, MTAP | TSHR 1870/4885EPHX1 3540/4885POLB 421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.